Immune and Safety Analysis of <i>ultra</i>IPV^TM, a Novel UVC-Inactivated Polio Vaccine.

ABSTRACT: The eradication of poliovirus remains a global health priority, with inactivated polio vaccines (IPVs) playing a pivotal role in immunization strategies. Over the past decades, advancements in IPV production have focused on optimizing safety, efficacy, and immunogenicity while addressing vaccine production and logistical challenges. This paper discusses a novel IPV candidate, ultraIPV^TM, which departs from conventional formalin inactivation and uses a modern ultraviolet C (UVC) inactivation technology that includes a powerful antioxidant that protects virus epitopes from damage during and after irradiation. The potential of UVC inactivation to maintain structural integrity and immunogenicity of viral antigens, while circumventing safety issues with conventional vaccines,

SUBMITTER: MacLeod DA 

PROVIDER: S-EPMC12300962 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature